Jazz Pharmaceuticals (JAZZ) Reports In-Line Q4 EPS, FY Guidance Comes in Light
Go back to Jazz Pharmaceuticals (JAZZ) Reports In-Line Q4 EPS, FY Guidance Comes in Light| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 241.46 +0.72 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $240.74 | 52 Week High | $160.00 | |||
| Open | $240.87 | 52 Week Low | $95.80 | |||
| Day High | $244.49 | P/E | 44.88 | |||
| Day Low | $238.53 | EPS | $5.38 | |||
| Volume | 499,154 | |||||
